Agilent Technologies Inc
NYSE:A

Watchlist Manager
Agilent Technologies Inc Logo
Agilent Technologies Inc
NYSE:A
Watchlist
Price: 133.84 USD 1.35% Market Closed
Market Cap: 38.5B USD
Have any thoughts about
Agilent Technologies Inc?
Write Note

Agilent Technologies Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Agilent Technologies Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Agilent Technologies Inc
NYSE:A
Revenue
$6.5B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
13%
Thermo Fisher Scientific Inc
NYSE:TMO
Revenue
$42.4B
CAGR 3-Years
3%
CAGR 5-Years
11%
CAGR 10-Years
10%
Danaher Corp
NYSE:DHR
Revenue
$21.2B
CAGR 3-Years
-9%
CAGR 5-Years
6%
CAGR 10-Years
1%
West Pharmaceutical Services Inc
NYSE:WST
Revenue
$2.9B
CAGR 3-Years
2%
CAGR 5-Years
10%
CAGR 10-Years
7%
Mettler-Toledo International Inc
NYSE:MTD
Revenue
$3.8B
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
4%
IQVIA Holdings Inc
NYSE:IQV
Revenue
$15.3B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
11%
No Stocks Found

Agilent Technologies Inc
Revenue Breakdown

Breakdown by Geography
Agilent Technologies Inc

Total Revenue: 6.8B USD
100%
Rest Of World: 3B USD
44.5%
Americas: 2.7B USD
40%
United States: 2.4B USD
35.3%
Asia Pacific: 2.3B USD
34.3%
Europe: 1.8B USD
25.7%
China Including Hong Kong: 1.4B USD
20.2%
Show More
Show Less

Breakdown by Segments
Agilent Technologies Inc

Total Revenue: 6.8B USD
100%
Products: 5.1B USD
73.9%
Non-Instrumentation And Other: 4.1B USD
59.9%
Life Sciences And Applied Markets: 3.9B USD
56.4%
Instrumentation: 2.7B USD
40.1%
Services And Other: 1.8B USD
26.1%
Agilent Crosslab: 1.6B USD
22.9%
Diagnostics And Genomics: 1.4B USD
20.6%
Show More
Show Less

Agilent Technologies Inc
Glance View

Market Cap
38.5B USD
Industry
Life Sciences Tools & Services

Agilent Technologies Inc. is a leading global innovator in life sciences, diagnostics, and applied chemical markets, embodying a commitment to advancing scientific discovery and improving healthcare outcomes. Founded in 1999 as a spin-off from Hewlett-Packard, Agilent has strategically positioned itself at the nexus of key industries where powerful analytical tools and technologies are essential. The company's robust portfolio includes sophisticated instruments, software, and services that facilitate groundbreaking research in pharmaceuticals, environmental monitoring, and food safety, making it an indispensable partner for laboratories and research institutions worldwide. With a focus on precision and efficiency, Agilent's solutions enable businesses and scientists to make informed decisions that drive progress in health and safety. Investors are drawn to Agilent not only for its impressive technological capabilities but also for its strong financial performance and a clear growth strategy rooted in innovation and customer collaboration. The company has leveraged its expertise in mass spectrometry, chromatography, and genomics to enhance its offering, tapping into rising trends in personalized medicine and biopharmaceutical development. This dedication to growth is reflected in Agilent's consistent revenue increases and healthy profit margins, underscoring its resilience in a competitive marketplace. As the world increasingly turns toward data-driven approaches in science and healthcare, Agilent stands out as a critical player, promising robust returns for investors seeking exposure to a company that is shaping the future of science and technology.

A Intrinsic Value
114.62 USD
Overvaluation 14%
Intrinsic Value
Price

See Also

What is Agilent Technologies Inc's Revenue?
Revenue
6.5B USD

Based on the financial report for Jul 31, 2024, Agilent Technologies Inc's Revenue amounts to 6.5B USD.

What is Agilent Technologies Inc's Revenue growth rate?
Revenue CAGR 10Y
13%

Over the last year, the Revenue growth was -7%. The average annual Revenue growth rates for Agilent Technologies Inc have been 2% over the past three years , 5% over the past five years , and 13% over the past ten years .

Back to Top